Form 4: GeneDx Holdings Corp. CEO Katherine Stueland Executes Stock Transactions to Cover Tax Obligations

Katherine Stueland, CEO of GeneDx Holdings Corp., reports transactions involving Class A Common Stock, including the vesting and sale of restricted stock units to cover tax withholding obligations.

Summary

• On March 26, 2025, Katherine Stueland, CEO of GeneDx Holdings Corp., executed transactions involving the company's Class A Common Stock.
• These transactions included the vesting of 80,000 restricted stock units (RSUs) and the subsequent sale of shares to cover tax withholding obligations.
• Specifically, 44,801 shares were sold at $95.6577 each, and 1,750 shares were sold at $94.585 each.
• Following these transactions, Stueland directly owns 48,314 shares of Class A Common Stock and 240,000 restricted stock units.
• The RSUs vest in four equal annual installments starting March 26, 2025, contingent upon continued service to the Issuer.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation and tax obligations. There is no indication of positive or negative implications for the company's performance.

Positives

• The vesting of RSUs indicates a continued alignment of the CEO's interests with the company's performance.
• The 'sell to cover' transaction ensures that tax obligations are met without requiring the CEO to use personal funds.

Future Outlook

The remaining restricted stock units will continue to vest annually, subject to the Reporting Person's continued service to the Issuer.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The sale of shares to cover tax obligations is a common practice.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they primarily relate to the CEO's personal financial planning and tax obligations.
• The increased transparency through the Form 4 filing can reassure stakeholders about corporate governance practices.

Key Dates

Keywords

GeneDx Holdings Corp., Katherine Stueland, Class A Common Stock, Restricted Stock Units, RSU, Form 4, SEC, Tax Withholding, Vesting, Director, Officer